Search Results

RTA-408 5mg 5mg  | Purity Not Available

Adooq Bioscience

RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-kB.

More Information Supplier Page

RTA-408 25mg 25mg  | Purity Not Available

Adooq Bioscience

RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-kB.

More Information Supplier Page

RTA-408 10mg 10mg  | Purity Not Available

Adooq Bioscience

RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-kB.

More Information Supplier Page

Debio-1347 5mg 5mg  | Purity Not Available

Adooq Bioscience

Debio-1347 is an orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity.

More Information Supplier Page

Debio-1347 25mg 25mg  | Purity Not Available

Adooq Bioscience

Debio-1347 is an orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity.

More Information Supplier Page

Debio-1347 10mg 10mg  | Purity Not Available

Adooq Bioscience

Debio-1347 is an orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity.

More Information Supplier Page

Volitinib 10mg 10mg  | Purity Not Available

Adooq Bioscience

Volitinib is an orally bioavailable inhibitor of the c-Met receptor tyrosine kinase with potential antineoplastic activity.

More Information Supplier Page

Volitinib 25mg 25mg  | Purity Not Available

Adooq Bioscience

Volitinib is an orally bioavailable inhibitor of the c-Met receptor tyrosine kinase with potential antineoplastic activity.

More Information Supplier Page